Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Lapatinib and RAD-001
Sponsor: University of Kansas Medical Center
Collaborators: Novartis|GlaxoSmithKline